SARS-CoV-2 subvariant XEC: emerging challenges amidst the global decline of KP.3.1.1
Abstract The ongoing COVID-19 pandemic has seen the emergence of numerous SARS-CoV-2 variants, each posing distinct public health challenges. The XEC variant, a recombinant Omicron subvariant, has rapidly gained prevalence globally, raising critical questions about its potential implications on heal...
Saved in:
| Main Authors: | Seun Adegboyega Adejumo, Henry Chukwuma, Onyeka Chukwudalu Ekwebene |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | BMC Research Notes |
| Online Access: | https://doi.org/10.1186/s13104-025-07371-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antibody evasiveness of SARS-CoV-2 subvariants KP.3.1.1 and XEC
by: Qian Wang, et al.
Published: (2025-04-01) -
Entry Efficiency, Protease Dependence, and Antibody-Mediated Neutralization of SARS-CoV-2 Sublineages KP.3.1.1 and XEC
by: Prerna Arora, et al.
Published: (2025-04-01) -
Neutralization and spike stability of JN.1-derived LB.1, KP.2.3, KP.3, and KP.3.1.1 subvariants
by: Pei Li, et al.
Published: (2025-05-01) -
Super broad and protective nanobodies against Sarbecoviruses including SARS-CoV-1 and the divergent SARS-CoV-2 subvariant KP.3.1.1
by: Haodi Dong, et al.
Published: (2024-11-01) -
Emergence of the SARS-CoV-2 XEC subvariant: public health concerns and preparedness in Nigeria
by: Samuel Onuzulike Ebede, et al.
Published: (2025-07-01)